XML 49 R33.htm IDEA: XBRL DOCUMENT

Related Party Disclosures	12 Months Ended
Related Party Disclosures	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Disclosures	Related Party Disclosures The Company provides consulting services to PharmaCord, LLC. One of the Company’s directors, Nitin Sahney, is the member-manager and chief executive officer of PharmaCord, LLC. The Company recognized revenue of $225, $1,748 and $nil for the year ended December 31, 2018, 2017 and 2016, respectively, for services provided. As of December 31, 2018 and 2017, the Company had accounts receivable of $5 and $140, respectively, related to these services. On October 1, 2018, the Company entered into the Investment Agreement with the Purchaser relating to the issuance to the Purchaser of $150,000 aggregate principal amount of the Notes. In connection with the investment, Vikram S. Pandit, Chairman and CEO of The Orogen Group LLC (an affiliate of the Purchaser), was appointed to Company’s Board of Directors. Refer Note 19 to the consolidated financial statements for details. At December 31, 2018, the Company had outstanding Notes with a principle amount of $150,000 and interest accrued of $1,313 related to the Investment Agreement.